| MEDFX | REBAX | MEDFX / REBAX | |
| Total Expense Ratio | 1.07 | 1.11 | 96% |
| Annual Report Gross Expense Ratio | 1.08 | 1.11 | 97% |
| Fund Existence | 18 years | 20 years | - |
| Gain YTD | 2.817 | 2.645 | 106% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.64B | 370M | 2,064% |
| Annual Yield % from dividends | 5.16 | 4.76 | 108% |
| Returns for 1 year | 10.12 | 9.80 | 103% |
| Returns for 3 years | 31.45 | 30.99 | 101% |
| Returns for 5 years | 13.62 | 11.61 | 117% |
| Returns for 10 years | 42.14 | 37.26 | 113% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| EIPIX | 19.84 | 0.26 | +1.33% |
| EIP Growth and Income I | |||
| MLVPX | 18.72 | 0.23 | +1.24% |
| MFS Low Volatility Equity R3 | |||
| DISAX | 22.93 | 0.21 | +0.92% |
| BNY Mellon International Stock Fund A | |||
| QUERX | 18.73 | 0.04 | +0.21% |
| AQR Large Cap Defensive Style R6 | |||
| WCMIX | 28.35 | -0.08 | -0.28% |
| WCM Focused International Growth Instl | |||